Skip to main content
. 2022 Jun 10;23(14):e202200180. doi: 10.1002/cbic.202200180

Table 7.

In‐vitro (FRET) and in‐cellulo (BRET) binding data of selected inhibitors.

Compound

FRET assay (IC50) [nM]

BRET assay (EC50) [nM]

vorinostat (6)

200[a]

630[a]

quisinostat (11)

10

40[a]

abexinostat (12)

4

8[a]

tubastatin A (14)

19

13[a]

48 a

5

26

48 b

2

10

[a] From Géraldy et al. [32]